ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028

 

 

TABLE OF CONTENTS

 

1.     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET

2.2. KEY INSIGHTS

1.1.1.    INTRODUCTION OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT

1.1.2.    MODERN SEDENTARY LIFESTYLES

1.2. PORTER’S FIVE FORCES MODEL

1.1.1.    THREAT OF NEW ENTRANTS

1.1.2.    THREAT OF SUBSTITUTE PRODUCTS

1.1.3.    BARGAINING POWER OF BUYERS

1.1.4.    BARGAINING POWER OF SUPPLIERS

1.1.5.    COMPETITIVE RIVALRY

1.2. MARKET ATTRACTIVENESS INDEX

1.3. VENDOR SCORECARD

1.4. KEY STRATEGIC DEVELOPMENTS

1.1.1.    ACQUISITIONS & MERGERS

1.1.2.    PRODUCT LAUNCH & DEVELOPMENTS

1.1.3.    CONTRACTS AND PARTNERSHIPS

1.1.4.    BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

1.2. MARKET DRIVERS

1.1.1.    RISE IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE

1.1.2.    INCREASE IN PREVALENCE OF HORMONAL DISORDERS

1.1.3.    NEW PRODUCT LAUNCHES BY MAJOR GIANTS

1.2. MARKET RESTRAINTS

1.1.1.    HIGH COST OF TREATMENT

1.1.2.    ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY

1.2. MARKET OPPORTUNITIES

1.1.1.    AVAILABILITY OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH

1.1.2.    LAUNCH OF TELEMEDICINE CLINICAL PRACTICE SERVICES

2.     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE

2.1. ESTROGEN HORMONE REPLACEMENT THERAPY

2.2. THYROID HORMONE REPLACEMENT THERAPY

2.3. TESTOSTERONE HORMONE REPLACEMENT THERAPY

2.4. HUMAN GROWTH HORMONE REPLACEMENT THERAPY

2.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY

3.     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE

1.1. MENOPAUSE

1.2. MALE HYPOGONADISM

1.3. GROWTH HORMONE DEFICIENCY

1.4. HYPOTHYROIDISM

1.5. OTHER TYPE OF DISEASES

2.     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION

2.1. ORAL

2.2. PARENTERAL

2.3. TRANSDERMAL

2.4. OTHER ROUTES OF ADMINISTRATION

3.     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK

3.1. CHINA

3.2. JAPAN

3.3. INDIA

3.4. AUSTRALIA & NEW ZEALAND

3.5. SOUTH KOREA

3.6. ASEAN COUNTRIES

3.7. REST OF ASIA-PACIFIC

4.     COMPETITIVE LANDSCAPE

4.1. ABBOTT LABORATORIES

4.2. AMGEN

4.3. ANI PHARMACEUTICALS

4.4. BAYER AG

4.5. DR REDDY’S LABORATORIES LTD

4.6. ELI LILLY & COMPANY

4.7. GENENTECH INC

4.8. IPSEN

4.9. MERCK KGAA

4.10.               NOVARTIS AG

4.11.               NOVEN PHARMACEUTICALS INC

4.12.               NOVO NORDISK A/S

4.13.               PFIZER INC

4.14.               TEVA PHARMACEUTICAL INDUSTRIES LTD

4.15.               VIATRIS INC (MYLAN NV)

5.     RESEARCH METHODOLOGY & SCOPE

5.1. RESEARCH SCOPE & DELIVERABLES

1.1.1.    OBJECTIVES OF STUDY

1.1.2.    SCOPE OF STUDY

1.2. SOURCES OF DATA

1.1.1.    PRIMARY DATA SOURCES

1.1.2.    SECONDARY DATA SOURCES

1.2. RESEARCH METHODOLOGY

1.1.1.    EVALUATION OF PROPOSED MARKET

1.1.2.    IDENTIFICATION OF DATA SOURCES

1.1.3.    ASSESSMENT OF MARKET DETERMINANTS

1.1.4.    DATA COLLECTION

1.1.5.    DATA VALIDATION & ANALYSIS

 

 

LIST OF TABLES

 

TABLE 1:      ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:      VENDOR SCORECARD

TABLE 3:      LIST OF ACQUISITIONS & MERGERS

TABLE 4:      LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 5:      LIST OF CONTRACTS AND PARTNERSHIPS

TABLE 6:      ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 7:      ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 8:      ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 9:      ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

 

FIGURE 1:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)

FIGURE 3:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 4:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 5:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 6:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 7:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 8:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)

FIGURE 9:    ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

FIGURE 10:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

FIGURE 11:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

FIGURE 12:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

FIGURE 13:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)

FIGURE 14:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)

FIGURE 15:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 16:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

FIGURE 17:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

FIGURE 18:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

FIGURE 19:  CHINA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  JAPAN HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  INDIA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  AUSTRALIA & NEW ZEALAND HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  ASEAN COUNTRIES HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  REST OF ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

 

 

 

MARKET OUTLOOK

 

Triton’s research report on the Asia-Pacific hormone replacement therapy market suggests that the market is envisioned to grow at a CAGR of 8.45% through the years 2021-2028. Australia & New Zealand, India, ASEAN countries, China, South Korea, Japan, and Rest of APAC shape the overall region’s market.

The studied market’s growth in India is motivated mainly by the growing number of geriatric populations. However, due to high cost of hormone replacement therapy has slowed the market’s growth. Nevertheless, in the last decade, hormone replacement therapy has gained momentum in the country, owing to the rise in women opting for these therapies to treat menopausal symptoms, including osteoporosis and osteopenia. These factors suggest the moderate growth of the hormone replacement therapy market over the forecast period across India.

On the other hand, in South Korea, it is estimated that the female population will exceed the male population significantly by 2060. Here, a majority of women are expected to suffer from menopausal symptoms. This increase in menopausal symptoms is likely to increase the demand for hormonal replacement drugs across the country. Furthermore, prominent manufacturers establishing businesses for hormone replacement therapy are likely to fuel the development of the studied market over the forecast period. Additionally, a significant number of the Korean transgender population goes through some type of hormone therapy, adding to the hormone replacement therapy market’s growth within South Korea.

 

 

COMPETITIVE OUTLOOK

 

The well-known companies in the hormone replacement therapy market comprise Eli Lilly & Company, Teva Pharmaceutical Industries Ltd, Dr Reddy’s Laboratories Ltd, Noven Pharmaceuticals Inc, Genentech Inc, Ipsen, and ANI Pharmaceuticals.

 

 

Get more insights into the Asia-Pacific Hormone Replacement Therapy Market:

 

https://www.tritonmarketresearch.com/reports/asia-pacific-hormone-replacement-therapy-market

 

 

SEGMENTATION

 

1.     ABBOTT LABORATORIES

2.     AMGEN

3.     ANI PHARMACEUTICALS

4.     BAYER AG

5.     DR REDDY’S LABORATORIES LTD

6.     ELI LILLY & COMPANY

7.     GENENTECH INC

8.     IPSEN

9.     MERCK KGAA

10. NOVARTIS AG

11. NOVEN PHARMACEUTICALS INC

12. NOVO NORDISK A/S

13. PFIZER INC

14. TEVA PHARMACEUTICAL INDUSTRIES LTD

15. VIATRIS INC (MYLAN NV)

 

Comments

Post a Comment

Popular posts from this blog

NORTH AMERICA BIOCHAR MARKET 2022-2028

    TABLE OF CONTENTS 1. NORTH AMERICA BIOCHAR MARKET - SUMMARY 2. INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON BIOCHAR MARKET 2.2. KEY INSIGHTS 2.2.1. PYROLYSIS IS THE MOST COMMON TECHNIQUE FOR BIOCHAR PRODUCTION 2.2.2. AGRICULTURE DOMINATES THE APPLICATION SEGMENT 2.2.3. GROWING NEED TO AVOID BIOCHAR LOSS DURING APPLICATION AND TRANSPORTATION 2.3. PORTER’S FIVE FORCES ANALYSIS 2.3.1. THREAT OF NEW ENTRANTS 2.3.2. THREAT OF SUBSTITUTES 2.3.3. BARGAINING POWER OF BUYERS 2.3.4. BARGAINING POWER OF SUPPLIERS 2.3.5. THREAT OF COMPETITIVE RIVALRY 2.4. KEY IMPACT ANALYSIS 2.5. MARKET ATTRACTIVENESS INDEX 2.6. VENDOR SCORECARD 2.7. INDUSTRY COMPONENTS 2.8. REGULATORY FRAMEWORK 2.9. KEY MARKET STRATEGIES 2.9.1. PRODUCT LAUNCHES & DEVELOPMENTS 2.9.2. PARTNERSHIPS & AGREEMENTS 2.10. MARKET DRIVERS 2.10.1. FAVORABLE INITIATIVES 2.10.2. AVAILABILITY OF CHEAP FEEDSTOCK 2.10.3. ABILITY OF BIOCHAR TO SEQUESTER CARBON 2.10.4. RELIA...
Read more

ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET 2021-2026

    TABLE OF CONTENT 1.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET –SUMMARY 1.1. COUNTRY SNAPSHOT 1.2. MARKET SIZE & FORECAST 1.3. MARKET DRIVING ASPECTS 1.4. MARKET RESTRAINING ASPECTS 1.5. KEY PLAYERS 2.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET OUTLOOK 2.1. IMPACT OF COVID-19 ON ITALY ALCOHOLIC RTDS MARKET 2.2. PESTLE ANALYSIS 2.2.1.     POLITICAL 2.2.2.     ECONOMICAL 2.2.3.     SOCIAL 2.2.4.     TECHNOLOGICAL 2.2.5.     LEGAL 2.2.6.     ENVIRONMENTAL 2.3. MARKET ATTRACTIVENESS INDEX 2.4. MARKET SHARE ANALYSIS OF KEY PLAYERS 2.5. BRAND SHARE ANALYSIS 3.      ITALY ALCOHOLIC RTD MARKET SEGMENTATION - BY RTD TYPE (IN TERMS OF VALUE: $ MILLION & IN TERMS OF VOLUME: MILLION LITRES) 3.1. SPIRIT-BASED RTDS 3.2. WINE-BASED RTDS 4.    ...
Read more

GLOBAL ENTERPRISE RESOURCE PLANNING MARKET 2022-2028

    TABLE OF CONTENTS   1.      GLOBAL ENTERPRISE RESOURCE PLANNING MARKET - SUMMARY 2.      INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON ENTERPRISE RESOURCE PLANNING MARKET 2.2. PARENT MARKET ANALYSIS: ENTERPRISE APPLICATION MARKET 2.3. TIMELINE OF ENTERPRISE RESOURCE PLANNING (ERP) 2.4. KEY INSIGHTS 2.4.1.     EMERGENCE OF CLOUD ERP 2.4.2.     SOCIAL NETWORKING IS GAINING IMPORTANCE AMONG ERP MERCHANTS 2.4.3.     INTEGRATED ERP IS ONE OF THE PROMINENT EMERGING TRENDS 2.4.4.     ACQUISITION HAS EMERGED AS A PRIMARY GROWTH STRATEGY 2.5. PORTER’S FIVE FORCES ANALYSIS 2.5.1.     THREAT OF NEW ENTRANTS 2.5.2.     THREAT OF SUBSTITUTES 2.5.3.     BARGAINING POWER OF BUYERS 2.5.4.     BARGAINING POWER OF SUPPLIERS 2.5.5.     THREAT OF COMPETITIVE RIVALRY 2.6. KEY...
Read more